Weekly versus 3-weekly paclitaxel in combination with carboplatin in advanced ovarian cancer: which is the optimal adjuvant chemotherapy regimen?

10.3802/jgo.2018.29.e96

Saved in:

Bibliographic Details
Main Authors:	Lee, Matilda X, Tan, David SP
Other Authors:	MEDICINE
Format:	Review
Language:	English
Published:	KOREAN SOC GYNECOLOGY ONCOLOGY & COLPOSCOPY 2021
Subjects:	Science & Technology Life Sciences & Biomedicine Oncology Obstetrics & Gynecology Epithelial Ovarian Cancer Paclitaxel Chemotherapy Pharmacogenetics PHASE-III TRIAL GYNECOLOGIC-ONCOLOGY-GROUP PRIMARY PERITONEAL CANCER EPITHELIAL OVARIAN MOLECULAR SUBTYPES BRCA2 MUTATIONS FALLOPIAN-TUBE OPEN-LABEL CONVENTIONAL PACLITAXEL STAGE-III
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/206511
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

id	sg-nus-scholar.10635-206511
record_format	dspace
spelling	sg-nus-scholar.10635-2065112024-10-26T21:37:49Z Weekly versus 3-weekly paclitaxel in combination with carboplatin in advanced ovarian cancer: which is the optimal adjuvant chemotherapy regimen? Lee, Matilda X Tan, David SP MEDICINE Assoc Prof Shao Peng, David Tan Science & Technology Life Sciences & Biomedicine Oncology Obstetrics & Gynecology Epithelial Ovarian Cancer Paclitaxel Chemotherapy Pharmacogenetics PHASE-III TRIAL GYNECOLOGIC-ONCOLOGY-GROUP PRIMARY PERITONEAL CANCER EPITHELIAL OVARIAN MOLECULAR SUBTYPES BRCA2 MUTATIONS FALLOPIAN-TUBE OPEN-LABEL CONVENTIONAL PACLITAXEL STAGE-III 10.3802/jgo.2018.29.e96 JOURNAL OF GYNECOLOGIC ONCOLOGY 29 6 2021-11-16T10:10:12Z 2021-11-16T10:10:12Z 2018-11-01 2021-11-15T11:24:23Z Review Lee, Matilda X, Tan, David SP (2018-11-01). Weekly versus 3-weekly paclitaxel in combination with carboplatin in advanced ovarian cancer: which is the optimal adjuvant chemotherapy regimen?. JOURNAL OF GYNECOLOGIC ONCOLOGY 29 (6). ScholarBank@NUS Repository. https://doi.org/10.3802/jgo.2018.29.e96 20050380 20050399 https://scholarbank.nus.edu.sg/handle/10635/206511 en KOREAN SOC GYNECOLOGY ONCOLOGY & COLPOSCOPY Elements
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
language	English
topic	Science & Technology Life Sciences & Biomedicine Oncology Obstetrics & Gynecology Epithelial Ovarian Cancer Paclitaxel Chemotherapy Pharmacogenetics PHASE-III TRIAL GYNECOLOGIC-ONCOLOGY-GROUP PRIMARY PERITONEAL CANCER EPITHELIAL OVARIAN MOLECULAR SUBTYPES BRCA2 MUTATIONS FALLOPIAN-TUBE OPEN-LABEL CONVENTIONAL PACLITAXEL STAGE-III
spellingShingle	Science & Technology Life Sciences & Biomedicine Oncology Obstetrics & Gynecology Epithelial Ovarian Cancer Paclitaxel Chemotherapy Pharmacogenetics PHASE-III TRIAL GYNECOLOGIC-ONCOLOGY-GROUP PRIMARY PERITONEAL CANCER EPITHELIAL OVARIAN MOLECULAR SUBTYPES BRCA2 MUTATIONS FALLOPIAN-TUBE OPEN-LABEL CONVENTIONAL PACLITAXEL STAGE-III Lee, Matilda X Tan, David SP Weekly versus 3-weekly paclitaxel in combination with carboplatin in advanced ovarian cancer: which is the optimal adjuvant chemotherapy regimen?
description	10.3802/jgo.2018.29.e96
author2	MEDICINE
author_facet	MEDICINE Lee, Matilda X Tan, David SP
format	Review
author	Lee, Matilda X Tan, David SP
author_sort	Lee, Matilda X
title	Weekly versus 3-weekly paclitaxel in combination with carboplatin in advanced ovarian cancer: which is the optimal adjuvant chemotherapy regimen?
title_short	Weekly versus 3-weekly paclitaxel in combination with carboplatin in advanced ovarian cancer: which is the optimal adjuvant chemotherapy regimen?
title_full	Weekly versus 3-weekly paclitaxel in combination with carboplatin in advanced ovarian cancer: which is the optimal adjuvant chemotherapy regimen?
title_fullStr	Weekly versus 3-weekly paclitaxel in combination with carboplatin in advanced ovarian cancer: which is the optimal adjuvant chemotherapy regimen?
title_full_unstemmed	Weekly versus 3-weekly paclitaxel in combination with carboplatin in advanced ovarian cancer: which is the optimal adjuvant chemotherapy regimen?
title_sort	weekly versus 3-weekly paclitaxel in combination with carboplatin in advanced ovarian cancer: which is the optimal adjuvant chemotherapy regimen?
publisher	KOREAN SOC GYNECOLOGY ONCOLOGY & COLPOSCOPY
publishDate	2021
url	https://scholarbank.nus.edu.sg/handle/10635/206511
_version_	1821192461779730432

Weekly versus 3-weekly paclitaxel in combination with carboplatin in advanced ovarian cancer: which is the optimal adjuvant chemotherapy regimen?

Similar Items